Taking into account that VEGF is a pleiotropic cytokine and strong proangiogenic mediator, and additionally that it is observed in the areas of granuloma formation [18, 28], in our study we decided to assess the immunoexpression level in sarcoidosis patients. This evidence concerns the gene VEGFA and sarcoidosis.